Post Karin Conde-Knape, Senior Vice President of Global Drug Discovery at Novo Nordisk, about NLSDays Grand Opening
Post Mike Ryan, Executive Vice President, Europe, Eversana about NLSDays’ Vaccine Crosslinks: From Cancer to COVID super session
Post Michael Engsig, CEO, Nykode Therapeutics about NLSDays’ Vaccine Crosslinks: From Cancer to COVID super session
Post Dr. Richard Stratford, the CEO of NEC Oncoimmunity about NLSDays’ Vaccine Crosslinks: From Cancer to COVID super session
Post Dr. Carl Kilander, Partner, Healthcapabout NLSDays’ Vaccine Crosslinks: From Cancer to COVID super session
Post Dr. Gunnveig Grødeland, Research Group Lead, Influenza and Adaptive Immunity, Institute for Clinical Medicine, University of Oslo
